IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Epidemiology of Renal Disease in Thrissur – A Biopsy Audit

Review Article, Volume 05 Issue 3 – July to September 2012

Authors

Mary Grace, Assistant Professor, Department of General Medicine, Government Medical College, Thrissur


Abstract

The audit has thrown light into the prevalence of various kidney diseases occurring in population of Thrissur district. The younger age group needed biopsy the most. Primary glomerular diseases are the most common renal diseases in our setting. Among the primary glomerular diseases it is nephrotic syndrome which is the most commonly biopsied. FSGS is the most common cause of nephrotic syndrome. IgA nephropathy is the most common primary glomerular disease. Lupus nephritis is the most common cause for secondary glomerular disease. The proportion of males among the patients with lupus nephritis is slightly higher than usual. Crescentic Glomerulonephritis is an important cause of acute renal failure, while diabetes mellitus is the most common situation where biopsy is done for chronic renal disease. The elderly population has a greater incidence of post infectious proliferative Glomerulonephritis while compared to data from developed countries.

Keywords: Renal biopsy, IgA nephropathy, Glomerular diseases


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician